Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683163 · ClinicalTrials.gov registry record · Phase 2
PTH & Ibandronate Combination Study (PICS)
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT00683163 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 44 participants.
The verdict
NCT00683163, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study will test in several innovative ways, several different combinations of PTH and oral monthly ibandronate for the treatment of osteoporosis in postmenopausal women. The intension is to provide other options for treatment than the current standard 2 year course of drug therapy. These options may lead to treatment where the two years of therapy are spread over several years.
Interventions
- DRUG Ibandronate
- OTHER Placebo pills
- OTHER Placebo injection
- DRUG PTH(1-84)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00683163
The ClinicalTrials.gov registry entry for NCT00683163 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ibandronate is the first listed.
NCT00683163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00683163 about?
NCT00683163 is a clinical study titled "PTH & Ibandronate Combination Study (PICS)". This study will test in several innovative ways, several different combinations of PTH and oral monthly ibandronate for the treatment of osteoporosis in postmenopausal women. The intension is to provide other options for treatment than the current standard 2 year course of drug therapy. These option...
What is the current status of trial NCT00683163?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2008-05. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00683163?
The interventions under investigation include: Ibandronate (DRUG), Placebo pills (OTHER), Placebo injection (OTHER), PTH(1-84) (DRUG).
Who is sponsoring clinical trial NCT00683163?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.